Today in Science: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Today in Science.

Press releases published on July 10, 2026

Jul. 10, 2026

Cosmos Health Launches Subscription Model

Indeterminate GlobeNewswire

Jul. 10, 2026

Microscopy Market to Grow from USD 8.81 Billion in 2025 to USD 11.44 Billion by 2031, at a CAGR of 5.5% – MarketsandMarkets™

Indeterminate GlobeNewswire

Jul. 10, 2026

SourcingGPT Revolutionizes Trade Show Sourcing at Eletrolar Show 2026

Indeterminate GlobeNewswire

Jul. 10, 2026

AI Revolutionizes Cardiovascular Drug Development with $1.4+ Billion in Strategic Investments

Indeterminate GlobeNewswire

Jul. 10, 2026

Vmake Labs Launches Brainrot Marketing Video Styles to Help Small Businesses Turn Products into Viral Social Videos

Indeterminate GlobeNewswire

Jul. 10, 2026

HII to Host Second Quarter Earnings Conference Call and Webcast on July 30

Indeterminate GlobeNewswire

Jul. 10, 2026

Air Quality Monitoring Market to Reach US$ 14.37 Billion by 2034, Growing at 7.9% CAGR | The Insight Partners

Indeterminate GlobeNewswire

Jul. 10, 2026

Seegnal Announces Listing on the Frankfurt Stock Exchange

Indeterminate GlobeNewswire

Jul. 10, 2026

Sprout Social Named as a Visionary in the 2026 Gartner® Magic Quadrant™ for Social Media Management and Listening

Indeterminate GlobeNewswire

Jul. 10, 2026

Palisade Bio to Participate in the Leerink Partners Therapeutics Forum

Indeterminate GlobeNewswire

Jul. 10, 2026

Study Results of Orelabrutinib in Patients with SLE Published in the Journal of Autoimmunity

Indeterminate GlobeNewswire

Jul. 10, 2026

ParaZero Accelerates Active Counter-FPV Protection for Vehicles and High-Value Assets Amid Escalating Battlefield Threats

Indeterminate GlobeNewswire

Jul. 10, 2026

Press Release: Sanofi’s subcutaneous Sarclisa Escena approved in the US as first anticancer treatment administered via on-body injector

Indeterminate GlobeNewswire

Jul. 10, 2026

Communiqué de presse : Sarclisa Escena de Sanofi, la formulation sous-cutanée du Sarclisa, approuvé aux États-Unis comme premier traitement anticancéreux administré via un injecteur portable

Indeterminate GlobeNewswire

Jul. 10, 2026

Clearmind Medicine Responds to the U.S. Administration’s RFI for Addiction Treatment Innovations as Part of the Great American Recovery Initiative

Indeterminate GlobeNewswire

Jul. 10, 2026

Micware Commences Full-Scale Spatial Intelligence Business for the Web4 Era

Indeterminate GlobeNewswire

Jul. 10, 2026

ミックウェア、Web4時代の空間インテリジェンス事業を本格始動

Indeterminate GlobeNewswire

Jul. 10, 2026

NordLocker rebuilds its encrypted cloud storage from the ground up

Indeterminate GlobeNewswire

Jul. 10, 2026

PubHive Recognized as Best AI-Powered Scientific Workflow Platform 2026 – UK

Indeterminate EIN Presswire

Jul. 10, 2026

FUSMobile Surpasses 1,000 Patients Treated with Neurolyser® XR Across Eight(8) Countries

Indeterminate EIN Presswire